Sputum induction in COPD - It's safe, so now what do we do?

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 3, Issue 2, 2006, Pages 73-74

  Rand Sutherland, E ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRONCHODILATING AGENT; CORTICOSTEROID; SALBUTAMOL; SODIUM CHLORIDE;

ASTHMA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; EDITORIAL; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAFETY; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ASTHMA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SAFETY; SALINE SOLUTION, HYPERTONIC; SPUTUM;

EID: 33646679863     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550600651230     Document Type: Editorial

References (18)

1. Ovid MEDLINE. Accessed February 14, 2006.
2. Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ. Safety of sputum induction. Eur Respir J Suppl 2002; 37:9s-18s.
3. Wong HH, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997; 156:299-303.
4. Castagnaro A, Chetta A, Foresi A, D'Ippolito R, Malorgio R, Olivieri D. Effect of sputum induction on spirometric measurements and arterial oxygen saturation in asthmatic patients, smokers, and healthy subjects. Chest 1999; 116:941-945.
5. Umeno E, McDonald DM, Nadel JA. Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation. J Clin Invest 1990; 85:1905-1908.
6. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters SP, Sorkness C, Szefler SJ. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-1475.
7. Gershman NH, Wong HH, Liu JT, Mahlmeister MJ, Fahy JV. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur Respir J 1996; 9:2448-2453.
8. Wilson AM, Leigh R, Hargreave FE, Pizzichini MMM, Pizzichini E. Safety of sputum induction in moderate to severe smoking related chronic obstructive pulmonary disease. J COPD 2006; this issue.
9. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
10. Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, Pavord D. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001; 95:999-1002.
11. Rytila PH, Lindqvist AE, Laitinen LA. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000; 15:1116-1119.
12. Sutherland ER, Pak J, Langmack EL, Silkoff PE, Martin RJ. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002; 96:482-486.
13. Sutherland ER, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2689-2697.
14. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012.
15. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159:1043-1051.
16. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721.
17. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173.
18. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, Pavord ID. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2000; 356:1480-1485.